MARASTONI, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 10.188
AS - Asia 4.653
EU - Europa 2.219
SA - Sud America 701
Continente sconosciuto - Info sul continente non disponibili 108
AF - Africa 84
OC - Oceania 16
Totale 17.969
Nazione #
US - Stati Uniti d'America 9.985
SG - Singapore 1.727
CN - Cina 1.224
BR - Brasile 552
UA - Ucraina 520
VN - Vietnam 463
HK - Hong Kong 415
DE - Germania 367
TR - Turchia 358
GB - Regno Unito 297
IT - Italia 201
PL - Polonia 163
FR - Francia 162
FI - Finlandia 151
SE - Svezia 126
RU - Federazione Russa 94
JP - Giappone 92
MX - Messico 84
IN - India 77
CA - Canada 72
BD - Bangladesh 56
AR - Argentina 45
ZA - Sudafrica 39
ID - Indonesia 38
BE - Belgio 34
IQ - Iraq 34
CO - Colombia 33
NL - Olanda 26
PK - Pakistan 26
ES - Italia 23
CL - Cile 21
UZ - Uzbekistan 17
EC - Ecuador 16
AU - Australia 14
MY - Malesia 14
VE - Venezuela 14
JM - Giamaica 13
PH - Filippine 13
SA - Arabia Saudita 13
AE - Emirati Arabi Uniti 10
IR - Iran 10
LT - Lituania 10
MA - Marocco 10
JO - Giordania 9
NP - Nepal 8
KR - Corea 7
RO - Romania 7
TN - Tunisia 7
UY - Uruguay 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
PE - Perù 6
SV - El Salvador 6
GT - Guatemala 5
KE - Kenya 5
OM - Oman 5
PY - Paraguay 5
TH - Thailandia 5
AT - Austria 4
CH - Svizzera 4
CR - Costa Rica 4
EG - Egitto 4
HN - Honduras 4
KG - Kirghizistan 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
EE - Estonia 3
IL - Israele 3
LB - Libano 3
PA - Panama 3
PR - Porto Rico 3
QA - Qatar 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
AZ - Azerbaigian 2
DK - Danimarca 2
ET - Etiopia 2
HR - Croazia 2
HU - Ungheria 2
IE - Irlanda 2
LK - Sri Lanka 2
LY - Libia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
GM - Gambi 1
GY - Guiana 1
HT - Haiti 1
Totale 17.847
Città #
Singapore 1.104
Ashburn 1.037
Woodbridge 897
Fairfield 876
San Jose 670
Houston 586
Jacksonville 565
Ann Arbor 502
Chandler 433
Santa Clara 424
Hong Kong 407
Beijing 400
Seattle 339
Wilmington 310
Dallas 309
Cambridge 252
Council Bluffs 230
Izmir 174
Nanjing 170
Ho Chi Minh City 163
Warsaw 158
Los Angeles 129
Dearborn 127
Hanoi 121
Princeton 107
San Diego 105
Lauterbourg 90
Tokyo 90
New York 85
Boardman 74
Addison 68
São Paulo 67
Milan 59
Mexico City 58
Munich 49
Shenyang 48
Hefei 46
Nanchang 44
Brooklyn 38
Shanghai 38
Ferrara 37
Hebei 35
Brussels 34
Chicago 34
Helsinki 30
Jiaxing 29
London 29
Washington 29
Da Nang 27
Phoenix 27
Tianjin 27
San Francisco 25
Buffalo 23
Jinan 23
San Mateo 23
Falkenstein 22
Toronto 22
Auburn Hills 21
Porto Alegre 21
Rio de Janeiro 21
Turku 21
Bremen 19
Changsha 19
Frankfurt am Main 19
Haiphong 19
Orem 19
Baghdad 18
Johannesburg 18
Kunming 18
Mountain View 16
Zhengzhou 16
Boston 15
Chennai 15
Jakarta 15
Montreal 15
Moscow 15
Stockholm 15
Manchester 14
Philadelphia 14
Poplar 13
Tashkent 13
Atlanta 12
Denver 12
Falls Church 12
Guangzhou 12
Norwalk 12
Ningbo 11
Amsterdam 10
Belo Horizonte 10
Bogotá 10
Brasília 10
Columbus 10
Dong Ket 10
Hải Dương 10
Rome 10
The Dalles 10
Des Moines 9
Indiana 9
Redwood City 9
Augusta 8
Totale 12.530
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 423
A cyclic peptide T analogue with high chemotactic activity 297
C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors 269
Arecoline tripeptide inhibitors of proteasome 262
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 251
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 232
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells 231
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 231
Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors 225
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides 223
Vinyl ester-based cyclic peptide proteasome inhibitors 222
Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors 219
Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope 215
New class of proteasome 20S inhibitors: a crystallographic and molecular modelling study 214
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 213
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors 213
Calmodulin Binding Sites of the Skeletal, Cardiac, and Brain Ryanodine Receptor Ca2+ Channels: Modulation by the Catalytic Subunit of cAMP-Dependent Protein Kinase? 211
Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells 209
Peptide analogues of a subdominant epitope expressed in EBV-associated tumors: synthesis and immunological activity 207
Opioid agonists and antagonists. Peptides containing N-terminal allyl groups and/or a thiomethylene linkage in place of a peptide bond 205
A 500 MHz study of peptide T in a DMSO solution 205
A Bioactive Fullerene Peptide 204
Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues 203
Conformational analysis of peptide T and of its C‐pentapeptide fragment 199
Peptidyl vinyl ester derivatives: New class of selective inhibitors of proteasome trypsin-like activity 198
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes 197
N-Terminal-prolonged vinyl ester-based peptides as selective proteasome b1 subunit inhibitors 196
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes 196
α,β-Unsaturated N-Acylpyrrole Peptidyl Derivatives: New Proteasome Inhibitors 195
P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors 191
Synthesis, conformation and biological activity of dermorphin and deltorphin I analogues containing N-alkylglycine in place of residues in position 1, 3, 5 and 6 187
Structure–activity relationships of cyclic and linear peptide T analogues 185
Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors 184
Synthesis and opioid activity of partial retro‐inverso analogs of dermorphin 184
Amygdalin binds to the CD4 receptor as suggested from molecular modeling studies 182
Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors 181
Anodic mineralization of pentachlorophenol in alkaline media 179
CHEMOTACTIC RESPONSE OF HUMAN MONOCYTES TOWARDS LINEAR AND CYCLIC PEPTIDE T ANALOG 177
The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses 177
Synthesis and biological activity of carboxyl terminally extended dermorphins 177
Symmetry-based inhibitors of HIV-1 protease. Design, synthesis and preliminary structure-activity studies of acylated 2,3-diamino-1-hydroxypropanes and 2,4 diamino-1-hydroxybutanes 174
Synthesis and Pharmacological Activity of Partially Modified Retro-Inverso Dermorphin Tetrapeptides 171
Trypanocidal activity of peptidyl vinyl ester derivatives selective for inhibition of mammalian proteasome trypsin-like activity 169
Opioid deltorphin C analogues containing cis- or trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues 168
HIV-1 protease inhibitors containing an N-hydroxyamino acid core structure 168
Conformational properties of deltorphin: new features of the delta-opioid receptors 165
Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit 164
Synthesis and binding of 3-aminopyridine derivatives at central nicotinic receptors 163
Reversed-phase HPLC study on the in vitro enzymic degradation of dermorphin 162
Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides 161
Opioid peptides Synthesis and binding properties of dermorphin related heptapeptides 160
Synthesis and activity of N-benzyl pseudopeptides HIV protease inhibitors 159
Synthetic tetrapeptides related to dermorphin: Potent long lasting analgesic action following subcutaneous administration 159
New cyclic peptide proteasome inhibitors 159
Synthesis and Opioid Activity of Dermorphin Tetrapeptides Bearing D-Methionine S-Oxide at Position 2 159
Ammino Acidi Conformazionalmente Vincolati: Sintesi di un Analogo della Metionina 159
Direct electro-oxidation of bisphenol-A in aqueous alkaline media 158
Synthesis and activity of new acylated diaminohydroxyalkanes as human immunodeficiency virus protease inhibitors 155
Synthesis and Opioid Activity of [sar4]dermorphin-Tetrapeptide Analogues 155
Peptide-based cationic liposomes and micelles as a new tool for nonviral gene delivery 150
Synthesis and structure activity relationships of delthorphine analogues 149
Synthesis and biological properties of C-terminal vinyl ketone pseudotripeptides 149
Synthesis and activity of dermorphine growth hormone releasing factor hybrid peptides 148
Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues 147
Peptide T-AraC Conjugates. Solid Phase Synthesis and Biological Activity of N4-(acylpeptidyl)-AraC 147
In vivo measurement of ANP overall turnover and identification of its main metabolic pathways under steady state conditions in humans 147
Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope 145
analisi volumetricaper precipitazione, chelometria ed ossidoriduzione 144
Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals 140
Structure-activity relationships of HIV-1 protease inhibitors containing gem-diaminoserine core unit 138
Proteasome inhibitors: synthesis and activity of arecoline oxide tripeptide derivatives 138
Analisi volumetrica per precipitazione, chelometria ed ossidoriduzione 137
Opioid peptides. Biological study of (D-Meto2) dermorphin analogues in relation to the plurality of opioid receptors 136
Preparation of mono-radioiodinated tracers for study of the in vivo metabolism of atrial natriuretic peptide in humans 136
Opioid peptides. Partially modified retro-inverso dermorphin analogues 135
New features of the δ opioid receptor: Conformational properties of deltorphin I analogues 133
Synthesis and activity of pseudotripeptide inhibitors of HIV-1 protease containing D(-)-O-(benzyl)-tartaric acid 132
Rational design of dynorphin A analogues with delta-receptor selectivity and antagonism for delta- and kappa-receptors 131
Studies on the anti-phospholipase A2 and anti-inflammatory activities of a uteroglobin fragment and related peptides 130
Dehydro‐dermorphins: I. Influence of the stereo‐orientation of aromatic groups in dermorphin‐(1–5)‐peptides to opioid activity 129
Dehydro‐dermorphins: II. Synthesis and biological activity of unsaturated dermorphin hexa and heptapeptides 126
Synthesis and biological activity of chelator-peptide T conjugates 125
Identification of CD8+ T cell epitopes within lytic antigens of human herpes virus 8 125
Synthesis and activity of new linear and cyclic peptide T derivatives 124
Peptide-based molecules for the production of positive charged liposomes and micelles 123
Symmetry-based HIV protease inhibitors containing (S,S) or (R,R) tartaric acid core structure 121
New insights on μ/δ selectivity of opioid peptides: Conformational analysis of deltorphin analogues 121
Effects of peptide T derivatives on the proliferation of cultured human keratinocytes. 118
Structure-activity relationships of peptide T-related pentapeptides 116
C-terminal trans,trans-muconic acid ethyl ester partial retro-inverso pseudopeptides as proteasome inhibitors 116
CHEMOTACTIC RESPONSE OF HUMAN MONOCYTES TO PENTAPEPTIDE ANALOG DERIVED FROM IMMUNODEFICIENCY VIRUS PROTEIN gp120 113
Synthesis and biological activity of D-glucopyranosyl peptide T derivatives 112
Studies of anti-phospholipase A2 and anti-inflammatory activites of a synthetic nonapeptide from uteroglobin 112
Structure-activity relationships of dermorphin tetrapeptides carrying a ketomethylene linkage 111
null 107
null 107
Opioid peptides. Synthesis and biological properties of dermorphin, related hexapeptides 107
Synthesis and antiaggregatory activity of antiflammin related peptides 105
Synthesis and opioid activity of tyrosine sulfate containing dermorphin and deltorphin peptides 101
null 96
Totale 16.884
Categoria #
all - tutte 79.488
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.343
Totale 80.831


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.132 0 0 77 89 110 43 55 75 47 81 86 469
2022/20231.009 121 41 31 123 176 165 41 89 132 5 49 36
2023/2024565 47 76 50 13 62 131 17 28 3 5 10 123
2024/20251.851 41 31 145 54 288 155 12 129 307 199 304 186
2025/20265.986 652 290 733 745 772 363 649 278 537 708 191 68
2026/2027698 193 315 190 0 0 0 0 0 0 0 0 0
Totale 17.969